People · Operator

Julien Bradley

Named in public records as an officer, director or promoter · active 2020–2021 · Other Technology

1
Companies
2
Filings
$60.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
RedShift BioAnalytics, Inc.Other TechnologySeries B$60.5M$31.7M2020
Operator network

Julien Bradley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Bryson Hollimon · 4 companies · 1 sharedBryson HollimonFrank Smith · 4 companies · 1 sharedFrank SmithWilliam Cadogan · 3 companies · 1 sharedWilliam CadoganAmol Chaubal · 2 companies · 1 sharedAmol ChaubalCharles Purtell · 2 companies · 1 sharedCharles PurtellDon Bossi · 2 companies · 1 sharedDon BossiPaul Tardif · 2 companies · 1 sharedPaul TardifBryson Holliman · 1 companies · 1 sharedBryson HollimanCharles Marshall · 1 companies · 1 sharedCharles MarshallEugene Ma · 1 companies · 1 sharedEugene MaMark Cafazzo · 1 companies · 1 sharedMark CafazzoRob Carson · 1 companies · 1 sharedRob CarsonSusan Holleran · 1 companies · 1 sharedSusan HolleranThomas O'Lenic · 1 companies · 1 sharedThomas O'LenicWouter Meuleman · 1 companies · 1 sharedWouter MeulemanRedShift BioAnalytics, Inc. · $60.5M raisedRedShift BioAnalytics…Julien BradleyJB
Julien Bradley Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Julien Bradley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Bryson Hollimon14
Frank Smith14
William Cadogan13
Amol Chaubal12
Don Bossi12
Charles Purtell12
Paul Tardif12
Susan Holleran11
Wouter Meuleman11
Thomas O'Lenic11
Mark Cafazzo11
Bryson Holliman11
Eugene Ma11
Rob Carson11
Charles Marshall11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.